Back to discover
Disease

Orthomyxoviridae Infections

Late-stage therapeutic developmentEmerging researchCooling momentum
8
Publications
6
Clinical trials
2
Related conditions
1
Related proteins
2024
Latest publication
Current focus
Antibodies biologyTherapeutic developmentInflammation & immunityMetabolic & lifestyle factors

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Clinical trials

3 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
6
All trials
0
Active
2
Late-stage
6
Completed
Recently completed

Research activity

8 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Publications over time
20142024
Most influential
Major themes8
  • Influenza A virus3
  • Influenza, Human3
  • Orthomyxoviridae Infections3
  • Gastrointestinal Microbiome2
  • Bifidobacterium animalis1
  • Fomites1
  • Orthomyxoviridae1
  • Particulate Matter1
Leading journals6
  • Frontiers in immunology2
  • eLife1
  • Genome biology1
  • Nature communications1
  • The Journal of experimental medicine1
  • Virology journal1
Leading researchers8
  • Wei H2
  • Asadi S1
  • Barre RS1
  • Bouvier NM1
  • Cao G1
  • Chen LL1
  • Chen X1
  • Chen Y1
Affiliations (unnormalised)6
  • St. Jude Children's Research Hospital2
  • Air Quality Research Center1
  • College of Veterinary Medicine1
  • Hubei Key Laboratory of Agricultural Bioinformatics1
  • Icahn School of Medicine at Mount Sinai1
  • Imperial College London1

Disease biology

1 match

Key proteins & gene products studied in this disease. Number shows shared papers.

Related conditions

2 matches

Diseases frequently studied alongside this one. Number shows shared papers.

Disease profile

A grounded synthesis of the condition — overview, causes, mechanism, risk factors and current standard of care.

Overview

Orthomyxoviridae infections are viral diseases caused by members of the Orthomyxoviridae family. The supplied literature focuses mainly on influenza viruses, including influenza A and H9N2 avian influenza, which can cause severe respiratory illness in humans and animals and have zoonotic and pandemic potential.

Causes

These infections are caused by Orthomyxoviridae viruses, with influenza A viruses emphasized in the supplied grounding. H9N2 avian influenza viruses are described as widespread in poultry and capable of zoonotic infection, indicating animal reservoirs and cross-species transmission as relevant sources of infection.

Pathophysiology

Influenza A virus pathogenesis involves viral attachment, entry, and release from infected cells, with neuraminidase acting as a sialidase that cleaves sialic acids from host cell surfaces and nascent virions. The literature also describes overactivation of the innate immune response, leading to hypercytokinemia and immune-mediated injury, and notes that gut microbiota can modulate immune balance through the gut-lung axis.

Risk factors

Obesity is identified as a risk factor for increased severity and mortality in influenza A infection, with delayed and blunted antiviral responses and poorer recovery. The literature also highlights susceptibility shaped by the basal immune state, pre-existing immunity, and exposure to zoonotic avian influenza viruses such as H9N2 in poultry-associated settings.

Current standard of care

Vaccination is described as the traditional best way to prevent influenza A infection. The supplied reviews also discuss antiviral drug classes including neuraminidase inhibitors such as oseltamivir and the cap-dependent endonuclease inhibitor baloxavir, while noting that antiviral resistance and reduced vaccine effectiveness can limit control. Additional approaches under study include targeting neuraminidase and modulating the gut microbiota, but these are presented as investigational rather than established standard care.

AI-generated summary grounded in MeSH and 5 peer-reviewed sources. Informational only — not medical advice. Generated 2026-07-07.

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Virus diseases caused by the ORTHOMYXOVIRIDAE.

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.